Neuman

Selectis Health Makes Key Leadership Appointments

Retrieved on: 
Tuesday, December 19, 2023

Greenwood Village, CO, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") has appointed Jim Creamer as Interim Chief Financial Officer and Clifford Neuman to its board of directors. Creamer’s appointment is effective as of December 18, 2023, and Neuman’s appointment will be effective on January 1, 2024.

Key Points: 
  • Greenwood Village, CO, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") has appointed Jim Creamer as Interim Chief Financial Officer and Clifford Neuman to its board of directors.
  • Following a 15-year investment banking career, Creamer brings nearly 20 years of experience in public company leadership roles.
  • In addition to his role at Selectis, Creamer serves as the Principal of Corporate Solutions Advisors, LLC, which offers outsourced, fractional CFO services to small, growth-oriented companies across several industries.
  • “Jim’s extensive financial leadership and public company experience will enable us to strengthen Selectis’ financial controls and continue progressing our long-term strategic initiatives,” said Adam Desmond, interim CEO of Selectis.

Backstop Solutions Appoints Michael Neuman as the Firm's First Chief Information Security Officer

Retrieved on: 
Tuesday, July 26, 2022

CHICAGO, July 26, 2022 /PRNewswire/ -- Backstop Solutions Group, the industry's leading cloud-based productivity suite for institutional and alternative investors, today announced the appointment of Michael Neuman as the company's first Chief Information Security Officer (CISO).

Key Points: 
  • CHICAGO, July 26, 2022 /PRNewswire/ -- Backstop Solutions Group, the industry's leading cloud-based productivity suite for institutional and alternative investors, today announced the appointment of Michael Neuman as the company's first Chief Information Security Officer (CISO).
  • Neuman will also be responsible for the areas of privacy and trust, helping to expand Backstop's expertise in these evolving areas of regulation and compliance.
  • Neuman previously served as Vice President, Information Security at Backstop, where heplayed a significant role in providing the highest level of security and assurance to protect client data, including creating a process driven approach to work towards achieving FedRAMP certification.
  • Neuman, who joined Backstop in 2015, has more than 25 years of experience in technology and security.

Domain Capital Group Adds Patrick Neuman to Business Development Team

Retrieved on: 
Wednesday, October 6, 2021

Domain Capital Group, LLC, a comprehensive private investment management services firm, today announced the addition of Patrick Neuman as director of business development.

Key Points: 
  • Domain Capital Group, LLC, a comprehensive private investment management services firm, today announced the addition of Patrick Neuman as director of business development.
  • We believe Patrick has a unique skillset, having participated in capital market fundraising, business development and project management, said Patrick R. Leardo, executive managing director and CEO of Domain Capital Group.
  • Neuman previously served as director at Artist Capital Markets, where he secured funds for a variety of alternative investments.
  • As of June 30, 2021, Domain managed approximately $6.1 billion in total assets through its two registered subsidiaries, Domain Capital Advisors, LLC and Domain Timber Advisors, LLC.

Isosceles Pharmaceuticals appoints Herbert Neuman, MD, MBA Chief Medical Officer and adds Thomas Harrison, LH.D as a strategic advisor

Retrieved on: 
Tuesday, September 14, 2021

WILMINGTON, N.C., Sept. 14, 2021 /PRNewswire-PRWeb/ --Isosceles Pharmaceuticals welcomed two new team members -- Herbert Neuman, MD, MBA, and Thomas L. Harrison LH.D to their award-winning mission.

Key Points: 
  • WILMINGTON, N.C., Sept. 14, 2021 /PRNewswire-PRWeb/ --Isosceles Pharmaceuticals welcomed two new team members -- Herbert Neuman, MD, MBA, and Thomas L. Harrison LH.D to their award-winning mission.
  • Using synthetic cannabidiol manufactured under an FDA drug master file along with novel parenteral delivery systems Isosceles Pharmaceuticals is developing a platform of proprietary, non-opioid options.
  • Neuman has joined the company as chief medical officer, while Harrison will serve as a strategic advisor.
  • "Both Herb and Tom bring a level of industry and non-opioid pain expertise that enhances our efforts," said Bill Humphries, Chief Executive Officer of Isosceles Pharmaceuticals.

DirectTrust Acquires Assets of SAFE Identity

Retrieved on: 
Tuesday, August 31, 2021

WASHINGTON, Aug. 31, 2021 (GLOBE NEWSWIRE) -- DirectTrust today announced it has acquired the assets of SAFE Identity, including its Trust Framework.

Key Points: 
  • WASHINGTON, Aug. 31, 2021 (GLOBE NEWSWIRE) -- DirectTrust today announced it has acquired the assets of SAFE Identity, including its Trust Framework.
  • SAFE Identity (SAFE) is an industry consortium and certification body supporting identity assurance and cryptography in healthcare.
  • DirectTrust has created DirectTrust Identity, a new division, to house the SAFE Trust Framework.
  • Our acquisition of SAFE Identitys assets is truly a groundbreaking moment for DirectTrust and the entire electronic healthcare information industry, said Scott Stuewe, President and CEO of DirectTrust.

Stuart Neuman Named SVP Business Strategy For Quality Fragrance Group, A Division Of Parlux Holdings, Inc.

Retrieved on: 
Thursday, July 9, 2020

With over 30 years in the beauty business, Neuman brings a wealth of experience, long-standing relationships and an innovative merchandising approach to the company.

Key Points: 
  • With over 30 years in the beauty business, Neuman brings a wealth of experience, long-standing relationships and an innovative merchandising approach to the company.
  • Most recently, he served as VicePresident of Century 21 Department Store's Cosmetic and Fragrance Division where he was responsible for enhancing their product offerings with renownedinternational designer fragrance brands.
  • Neuman states, "There is tremendous opportunity to leverage the company's brand portfolio, expanddistribution, while forging new business partnerships."
  • Parlux LTD is a wholly owned subsidiary of Parlux Holdings,Inc.,an independent national, vertically integrated wholesale distributor of fragrances and related products.

Flipp Appoints New Chief Technology and Product Officer

Retrieved on: 
Wednesday, March 4, 2020

TORONTO, March 4, 2020 /PRNewswire/ - Today, Flipp, a leader in retail technology, announced that Rick Neuman has been named the company's first ever Chief Technology and Product Officer, reporting directly to Flipp's Chief Executive Officer.

Key Points: 
  • TORONTO, March 4, 2020 /PRNewswire/ - Today, Flipp, a leader in retail technology, announced that Rick Neuman has been named the company's first ever Chief Technology and Product Officer, reporting directly to Flipp's Chief Executive Officer.
  • "At Flipp our product and engineering teams work side-by-side and we wanted to ensure complete collaboration and alignment in the areas of innovation and design.
  • We have an extremely talented team of engineers and product professionals, so we were relentless in finding a phenomenal leader," said Wehuns Tan, Executive Chairman, Flipp.
  • Founded in 2007, Flipp is a retail technology company that is reinventing the digital shopping experience.

Evite Announces Appointment of Jay Neuman as Vice President of Data Science and Business Intelligence

Retrieved on: 
Tuesday, September 18, 2018

LOS ANGELES, Sept. 18, 2018 /PRNewswire/ --Evite, the world's leading online and text invitation service, today announced Jay Neuman has joined the company as Vice President of Data Science and Business Intelligence.

Key Points: 
  • LOS ANGELES, Sept. 18, 2018 /PRNewswire/ --Evite, the world's leading online and text invitation service, today announced Jay Neuman has joined the company as Vice President of Data Science and Business Intelligence.
  • Neuman reports to Chief Executive Officer Victor Cho and is based out of Evite's downtown Los Angeles headquarters.
  • "Jay has an incredibly broad and deep background in a number of critical areas that will be increasingly important as we grow Evite to the next level of scale and rigor," said Cho.
  • For over 20 years, Neuman has delivered data-driven business transformation by developing data science and business intelligence solutions for industry-leading companies.